Drug Profile
Baohuoside-1
Alternative Names: B-1Latest Information Update: 24 May 2007
Price :
$50
*
At a glance
- Originator University of Montreal
- Class Anti-inflammatories
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Transplant rejection
Most Recent Events
- 24 May 2007 Discontinued - Preclinical for Transplant rejection in Canada (unspecified route)
- 10 Jan 2005 Preclinical trials in Transplant rejection in Canada (unspecified route)